MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
RGC — Regencell Bioscience Holdings Limited Ordinary Shares
NasdaqRegencell Bioscience Holdings Limited Ordinary Shares
$7.11
-0.24(-3.27%)
- O
- 7.35
- H
- 7.35
- L
- 7.01
- V
- 109.63K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About RGC
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
IndustryCommon Stock
SectorNot available
IPO DateJul 16, 2021
Employees10
Stock ExchangeNasdaq
Ticker SymbolRGC
Key Financial Statistics
| Market Cap | $3.37B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $4.51 - $69.00 |
| 52-Week Avg Volume | 266.8K |
| VWAP | $7.15 |
| Transactions | 1,643 |
| Total Recorded Bars | 1,312 days |